Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medicine Man Technologies Inc (OP:SHWZ)

0.0022 UNCHANGED
Last Price Updated: 10:18 AM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medicine Man Technologies Inc

< Previous 1 2 3 4 5 Next >
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November. 
Via Benzinga
Topics Cannabis
Ka-Ching! Schwazze's Cannabis Accounting Bloopers And Other Historic Missteps That Shook Up Big Business
While Schwazze's issue may seem minor compared to past scandals, it serves as a reminder of how easily financial mistakes can spiral. 
Via Benzinga
Topics Cannabis
Schwazze's Q3 Preliminary Revenue Slides As Debt Grows, 2023 Financials Face Re-Audit
 
Via Benzinga
Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes
The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $162,000 per store. 
Via Benzinga
Topics Cannabis
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Removing 280E in 2025 could drastically improve cash flow for cannabis companies. See how major MSOs like Green Thumb, Trulieve, and Cresco.. 
Via Benzinga
Topics Cannabis
Schwazze Q2 Revenue Up 2% YoY, Net Loss Rises And Debt Remains High
 
Via Benzinga
Medicine Man Technologies: Q4 Earnings Insights
 
Via Benzinga
Earnings Outlook For Medicine Man Technologies
 
Via Benzinga
Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe
Viridian Capital Advisors provides cannabis investors with a more comprehensive EV calculation compared to traditional methods. 
Via Benzinga
Topics Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q2 2024
SHWZ stock results show that Medicine Man Technologies missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Out Of Pocket: Which U.S. Cannabis Company Owes The Most Money In 2024?
In a recent report, Pablo Zuanic, senior analyst at Zuanic & Associates, analyzes the debt maturities of over 20 multi-state operators (MSOs) in the cannabis industry. This comprehensive review follows... 
Via Benzinga
Topics Cannabis
Cannabis Companies About To Release Earnings Reports, Get Your News Here: Glass House, Schwazze And More
Glass House Brands Inc. (OTCQX: GLASF) (OTC: GHBWF) is about to report financial results for the second quarter ended June 30, 2024, on Tuesday, August 13, 2024, after market close.Medicine Man... 
Via Benzinga
Topics Cannabis
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following President Joe Biden’s Sunday announcement that he will not seek re-election. 
Via Benzinga
Topics Cannabis ETFs
Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
President Joe Biden's announcement that he will not seek re-election has impacted the cannabis stock market. 
Via Benzinga
Topics Cannabis
Schwazze Restructures Its $32M Debt Obligations, Improving Financials To Grow Across Colorado And New Mexico
 
Via Benzinga
7 Cannabis Stocks to Sell in July Before They Crash & Burn
With marijuana still facing legalization limbo, it's high time to bail on these seven cannabis stocks to sell. 
Via InvestorPlace
Topics Cannabis
Schwazze Cannabis Co Transitions To OTC Expert Market Due To Delayed Filing
 
Via Benzinga
Topics Cannabis
Here's Where To Buy Legal Weed: Nevada's Deep Roots Harvest Has New Owner, Shops In Three States That Just Launched Sales
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) has completed the previously announced acquisition of a 6,500-square-foot, purpose-built, operational retail cannabis dispensary in South Reno, Nevada.... 
Via Benzinga
Topics Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q1 2024
SHWZ stock results show that Medicine Man Technologies missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Schwazze's Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%
Medicine Man Technologies, Inc., operating as Schwazze (OTC: SHWZ), announced its financial results for the first quarter ended March 31, 2024. 
Via Benzinga
Topics Cannabis
Who's Who In Cannabis: Latest Executive Changes You Should Know About
 
Via Benzinga
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal... 
Via Benzinga
Topics Cannabis
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector. 
Via Benzinga
Topics Cannabis
Schwazze Records 8% Revenue Growth In Q4 2023 Amid Competitive Cannabis Retail Landscape (CORRECTED)
 
Via Benzinga
Topics Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Misses Revenue for Q4 2023
SHWZ stock results show that Medicine Man Technologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers
Colorado's cannabis market, once a frontrunner in the U.S. for recreational marijuana sales, has experienced a downturn. 
Via Benzinga
Topics Cannabis
Colorado Wants To Simplify Cannabis Regulations, Eliminate Fungus Testing: A 500-Page Rulebook Is Too Long, Lawmakers Say
Colorado lawmakers have introduced a bipartisan bill that aims to remove a rule requiring cannabis products to be tested for a fungus called Aspergillus. The rule, which was implemented by the Colorado... 
Via Benzinga
Topics Cannabis Product Recall
2024 Oscars Of Marijuana Equity: Analyst Nominations Spotlight Key State Performers
In his latest cannabis sector equity report, senior analyst Pablo Zuanic of Zuanic & Associates offers a detailed examination of the cannabis sector's landscape in the fourth quarter of 2023. 
Via Benzinga
Topics Cannabis
Tilray Brands And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Colorado's Pioneering Role In Legal Cannabis 10 Years On: Impact On Economy, Health And Public Policy
A decade ago, Colorado embarked on a historic journey, becoming the first U.S. state to legalize and regulate recreational marijuana sales on January 1, 2014, setting the stage for a transformative... 
Via Benzinga
Topics Cannabis Economy
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.